Epigenomics AG (Epigenomics AG) Days Sales Outstanding : 188.50 (As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Epigenomics AG Days Sales Outstanding?

Epigenomics AG's average Accounts Receivable for the three months ended in Jun. 2023 was $0.16 Mil. Epigenomics AG's Revenue for the three months ended in Jun. 2023 was $0.08 Mil. Hence, Epigenomics AG's Days Sales Outstanding for the three months ended in Jun. 2023 was 188.50.

The historical rank and industry rank for Epigenomics AG's Days Sales Outstanding or its related term are showing as below:

EPGNF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 7.03 Med: 59.42 Max: 311.84
Current: 84.73

During the past 13 years, Epigenomics AG's highest Days Sales Outstanding was 311.84. The lowest was 7.03. And the median was 59.42.

EPGNF's Days Sales Outstanding is ranked worse than
63.11% of 225 companies
in the Medical Diagnostics & Research industry
Industry Median: 69.24 vs EPGNF: 84.73

Epigenomics AG's Days Sales Outstanding increased from Jun. 2022 (42.88) to Jun. 2023 (188.50).

Epigenomics AG Days Sales Outstanding Historical Data

The historical data trend for Epigenomics AG's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epigenomics AG Days Sales Outstanding Chart

Epigenomics AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Sales Outstanding

Get a 7-Day Free Trial

131.64

28.18

52.22

7.47

29.11

Epigenomics AG Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Days Sales Outstanding	Get a 7-Day Free Trial															42.88	59.88	74.30	42.12	188.50

Competitive Comparison of Epigenomics AG's Days Sales Outstanding

For the Diagnostics & Research subindustry, Epigenomics AG's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Epigenomics AG's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Epigenomics AG's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Epigenomics AG's Days Sales Outstanding falls into.

Epigenomics AG Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Epigenomics AG's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

	Days Sales Outstanding (A: Dec. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )	/	Revenue (A: Dec. 2022 )	*	Days in Period
=	( (0.038	+	0.044)	/	2 )	/	0.514	*	365
=	0.041					/	0.514	*	365
=	29.11

Epigenomics AG's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding (Q: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (0.088	+	0.226)	/	2 )	/	0.076	*	365 / 4
=	0.157					/	0.076	*	365 / 4
=	188.50

Epigenomics AG (OTCPK:EPGNF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Epigenomics AG Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Epigenomics AG's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Epigenomics AG (Epigenomics AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Epigenomics AG (OTCPK:EPGNF) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

ECX:Germany

Address

Geneststrasse 5, Berlin, BB, DEU, 10829

Website

https://www.epigenomics.com

Epigenomics AG is a molecular diagnostics company, that focuses on developing and commercializing in vitro diagnostic liquid biopsy tests for the screening, early detection, and diagnosis of cancer. The company develops and markets procedures and devices for the production in quantity of particular epigenetic parameters such as DNA methylation patterns as well as the information technology bases necessary for their procurement and evaluation. It is engaged in the development of novel molecular diagnostic products for cancer. The company products include Epi proColon, Epi BiSKit, HCCBloodTest, and Epi proLung. The company operates in Europe, Asia, and North America, majority of its revenue derives from Asia.

Epigenomics AG (Epigenomics AG) Headlines

From GuruFocus

Encode Ideas, L.P. to host Virtual 1x1 Webinar with Epigenomics AG (ECX.DE, EPGNF) on Tuesday, July 28th at 10:30 AM ET

By ACCESSWIRE ACCESSWIRE • 07-23-2020